Pentosan Polysulfate Sodium Bioequivalence study [Regulatives / Guidelines]

posted by Dr_Dan  – 2010-09-23 11:26 (3877 d 13:19 ago) – Posting: # 5933
Views: 6,521

Dear Raja
In fact you can not perform a bioequivalence study if the drug is not systemically available due to very poor resorption (Bioavailability 0.4 - 3%). If a drug exhibits limited absorption but is highly soluble you could perform a BCS class III biowaiver. But to my knowledge this does not apply to pentosan polysulfate. So the only way to show therapeutic equivalence is to perform a pharmacodynamic or a comparative efficacy study.
Kind regards

Kind regards and have a nice day

Complete thread:

 Admin contact
21,444 posts in 4,482 threads, 1,509 registered users;
online 11 (0 registered, 11 guests [including 2 identified bots]).
Forum time: Thursday 00:45 CEST (Europe/Vienna)

In matters of style, swim with the current;
in matters of principle, stand like a rock.    Thomas Jefferson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz